Sidley Austin represented Squirrel Enlivened International Co., Ltd. in the transaction, and Robinson & Cole represented Horizon Space Acquisition I Corp. Squirrel Enlivened International Co., Ltd...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Zylox Tonbridge Medical Limited in the transaction, and Dorsey & Whitney represented Avinger, Inc. Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, “Zylox-Tonbridge”), a...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented OnCusp Therapeutics, Inc. in the transaction. OnCusp Therapeutics, Inc., a biopharmaceutical company, announced it has raised US$100 million (more than RMB700 million) Series A...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented SanReno Therapeutics in the transaction. Novartis, a global medicines company, announced the acquisition of clinical-stage company SanReno Therapeutics (SanReno). Following the acquisition’s closure, SanReno becomes...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Resolian in the transaction. Resolian, a global bioanalytical contract research organization (CRO), announced the acquisition of Denali Medpharma (Denali), a leading China-based bioanalytical CRO....
You must be a Standard 1 Year member to access this content.
Sidley advised I-Mab on the deal. I-Mab (Nasdaq: IMAB) obtained a victory in a multi-year long dispute over two collaboration agreements between I-Mab and Tracon Pharmaceuticals...
You must be a Standard 1 Year member to access this content.
Sidley represented Guardant Health on the deal. Guardant Health, Inc (Nasdaq: GH) announced its strategic partnership with Adicon to offer comprehensive genomic profiling tests to accelerate...
You must be a Standard 1 Year member to access this content.
Sidley represented Inspiration Capital Partners on the deal. Inspiration Capital Partners, a leading mid-market private equity firm focusing on growth and control investments in China’s healthcare,...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Vivo Capital and AdvanTech Capital on the deal. Vivo Capital and AdvanTech Capital acted as lead investors in the US$75 million Series A...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Vivo Capital and Novo Holdings A/S as lead investors on the deal, while Davis Polk advised Esco Lifesciences. Vivo Capital and Novo...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP and Kirkland & Ellis advised Zhaoke Ophthalmology Limited on the deal. Sullivan & Cromwell LLP advised the underwriters. Zhaoke Ophthalmology Limited (HKEX:6622) (Zhaoke)...
You must be a Standard 1 Year member to access this content.
